Bookmark
Forward
Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma.
Semra Paydas, Ali Ogul, Cem Irili, Serkan Gokcay
Annals of hematology 2016 Jan
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Semra Paydas, Ali Ogul, Cem Irili, Serkan Gokcay.
Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma.
Annals of hematology.
2016 Jan;95(1):145-6
Mesh Tags
Drug Resistance, Neoplasm
Hodgkin Disease
Humans
Immunoconjugates
Jaundice
Male
Middle Aged
Substances
Immunoconjugates
cAC10-vcMMAE
PMID: 26336969
View Full Text